|
Volumn 14, Issue 2, 2004, Pages 295-299
|
Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOANTIBODY;
COLLAGENASE;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B VACCINE;
VACCINE;
ANIMAL;
ARTICLE;
BIOSYNTHESIS;
C57BL MOUSE;
CHEMISTRY;
CYTOLOGY;
DENDRITIC CELL;
DENSITY GRADIENT CENTRIFUGATION;
HEPATITIS B VIRUS;
IMMUNOLOGICAL TOLERANCE;
IMMUNOTHERAPY;
KINETICS;
METABOLISM;
METHODOLOGY;
MOUSE;
PHENOTYPE;
SPLEEN;
TIME;
TRANSGENIC MOUSE;
VACCINATION;
ANIMALS;
AUTOANTIBODIES;
CENTRIFUGATION, DENSITY GRADIENT;
COLLAGENASES;
DENDRITIC CELLS;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VACCINES;
HEPATITIS B VIRUS;
IMMUNE TOLERANCE;
IMMUNOTHERAPY;
KINETICS;
MICE;
MICE, INBRED C57BL;
MICE, TRANSGENIC;
PHENOTYPE;
SPLEEN;
TIME FACTORS;
VACCINATION;
VACCINES;
|
EID: 11244276289
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.14.2.295 Document Type: Article |
Times cited : (45)
|
References (0)
|